Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against ACADIA, Rockwell Medical, and LogMeIn, and Encourages Investors to Contact the Firm

Bragar Eagel Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against ACADIA, Rockwell Medical, and LogMeIn, and Encourages Investors to Contact the Firm

NEW YORK, Aug. 21, 2018 (GLOBE NEWSWIRE) -- Bragar Eagel Squire, P.C. reminds investors that class action lawsuits have been commenced on behalf of stockholders of ACADIA Pharmaceuticals Inc., Rockwell Medical, Inc., and LogMeIn, Inc.  Stockholders have until the deadlines listed below to petition the court to serve as lead plaintiff.  Additional information about each case can be found at the link provided.

ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD)

Class Period: April 29, 2018 - July 9, 2018

Lead Plaintiff Deadline: September 17, 2018

The complaint alleges that throughout the Class Period, Defendants issued false and misleading statements to investors and failed to disclose that: (1) adverse events and safety concerns related to NUPLAZID threatened the drugs initial and continuing FDA approval; (2) ACADIA engaged in business practices likely to attract regulatory scrutiny; and (3) as a result, Defendant’s statements about ACADIA’s business, operations, and prospects, were materially false and/or misleading and/or lacked a reasonable basis at all relevant times.

To learn more about the ACADIA class action go to: https://bespc.com/acadia/.  

Rockwell Medical, Inc. (NASDAQ: RMTI)

Class Period: September 9, 2015 - February 29, 2016

Lead Plaintiff Deadline: September 25, 2018

The complaint alleges that throughout the Class Period, Defendants issued false and misleading statements to investors and failed to disclose that: (1) the primary product offering for Triferic will be in a powder packet packaging, which the FDA has not yet approved; (2) Rockwell is seeking to obtain transitional add-on payment reimbursement for Triferic with the Centers for Medicare Medicaid Services instead of bundled reimbursement; and (3) as a result, Defendant’s statements about Rockwell’s business, operations and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times.

To learn more about the Rockwell class action go to: http://bespc.com/rmti/.

LogMeIn, Inc. (NASDAQ: LOGM)

Class Period: March 1, 2017 - July 26, 2018

Lead Plaintiff Deadline: October 19, 2018

The complaint alleges that throughout the Class Period, Defendants issued false and misleading statements and failed to disclose that: (1) LogMeIn’s business practices had negatively impacted renewal rates for certain of its services; and (2) as a result, Defendant’s public statements were materially false and misleading at all relevant times.

To learn more about the LogMeIn class action go to: http://bespc.com/logmein/.

Bragar Eagel Squire, P.C. is a New York-based law firm concentrating in commercial and securities litigation.  For additional information about Bragar Eagel Squire, P.C. please go to www.bespc.com.

Contacts
Bragar Eagel Squire, P.C.
Brandon Walker, Esq.
Melissa Fortunato, Esq.
(212) 355-4648
[email protected]
www.bespc.com